Breast implants have a complex history that reflects advances in surgical technique, biomaterials, and changing medical and social priorities. Early attempts at breast augmentation and reconstruction in the late nineteenth and early twentieth centuries involved injectable substances such as paraffin, silicone oils, and other fillers. These methods were poorly understood and often led to severe complications, highlighting the need for safer and more controlled approaches. A major turning point occurred in 1962 with the introduction of the first modern silicone gel breast implant by Cronin and Gerow. These implants, consisting of a silicone elastomer shell filled with silicone gel, marked the beginning of contemporary breast implant surgery. Over subsequent decades, design evolved in response to clinical experience, outcomes, and safety concerns. Saline-filled implants were introduced as an alternative, and changes were made to shell thickness, surface texture, and implant shape to improve durability and performance. The history of breast implants also includes periods of controversy and regulatory scrutiny. In the late twentieth century, concerns about potential links between silicone implants and systemic disease led to increased scientific investigation and temporary restrictions in some countries. Large-scale epidemiological studies later contributed to a clearer understanding of risks, benefits, and complications, reinforcing the importance of evidence-based regulation and informed consent. Today, breast implants are used not only for cosmetic but also reconstructive purposes. Ongoing research focuses on improving biocompatibility, reducing complication rates, and developing alternative reconstructive techniques. Examining the history of breast implants provides insight into how medical innovation progresses through experimentation, regulation, and continual reassessment, illustrating broader themes in the development of modern surgical practice.